Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-3304

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-3304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Atorvastatin Calcium 80 mg film-coated tablets, carton label showing quantity of 30 tablets. Label includes NDC number 70518-3304-00, manufacturing information by Novadoz Pharmaceuticals LLC, and repackaging by RemedyRepack Inc. Directions advise to see package insert; storage conditions are 20-25°C with permitted excursions. The label is marked RX only.*

FDA Label Image

Figure-01 (Atorvastatin Figure 01)

A line graph presenting cumulative incidence (%) over time (years) comparing Atorvastatin versus Placebo. The solid line represents Atorvastatin with lower incidence, while the dashed line represents Placebo with higher incidence. Annotations include hazard ratio (HR=0.64) with confidence interval (0.50-0.83) and a p-value of 0.0005, indicating statistical comparison between groups.*

FDA Label Image

Figure-02 (Atorvastatin Figure 02)

A cumulative hazard curve comparing Atorvastatin and placebo over a period of up to 4 years. The x-axis represents the time to first primary endpoint in years, and the y-axis shows cumulative hazard percentage. The graph shows two lines, a solid line for Atorvastatin and a dashed line for placebo, with Atorvastatin having a lower cumulative hazard throughout the follow-up period.*

FDA Label Image

Figure-03 (Atorvastatin Figure 03)

A line graph comparing the percentage of subjects experiencing a cardiovascular event over time between Atorvastatin 10 mg and Atorvastatin 80 mg dosages. The x-axis represents years to the first major cardiovascular endpoint, ranging from 0 to 5 years, and the y-axis shows the percentage of subjects experiencing the event, from 0 to 0.2%. The graph includes a hazard ratio (HR 0.78) and p-value (0.0002) indicating statistical analysis results.*

FDA Label Image

Structure (Atorvastatin Structure)

Chemical structure of Atorvastatin calcium, showing the molecular arrangement including aromatic rings, hydroxyl groups, and calcium ion complex with hydration (3H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.